Stock Events

Stock Events

MediWound 

$18.26
0
+$0+0% Wednesday 07:08

Statistics

Day High
18.26
Day Low
18.26
52W High
-
52W Low
-
Volume
21
Avg. Volume
-
Mkt Cap
201.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2025
Q4 2025
Next
-0.81
-0.62
-0.43
-0.24
Expected EPS
-0.653333
Actual EPS
N/A

Financials

-149.46%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
40.44MRevenue
-60.45MNet Income

Analyst Ratings

$36.00Average Price Target
The highest estimate is 36.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDWD.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Soligenix
SNGX
Mkt Cap12.97M
Soligenix, Inc. is involved in developing products to treat serious inflammatory and biodefense conditions, competing directly with MediWound's wound care solutions.
Protalix BioTherapeutics
PLX
Mkt Cap188.97M
Protalix BioTherapeutics, Inc. focuses on rare diseases and has products that could compete in the wound healing market.
Amneal Pharmaceuticals
AMRX
Mkt Cap3.4B
Amneal Pharmaceuticals, Inc. has a broad portfolio that includes products potentially competitive with MediWound's in the generic and specialty pharmaceutical sectors.
ANI Pharmaceuticals
ANIP
Mkt Cap2.1B
ANI Pharmaceuticals, Inc. produces and markets a wide range of pharmaceuticals that could compete with MediWound's products in various therapeutic areas.
Collegium Pharmaceutical
COLL
Mkt Cap1.13B
Collegium Pharmaceutical, Inc. is dedicated to developing and commercializing products for pain management, which is directly related to the care and treatment of wounds.
Eagle Pharmaceuticals
EGRX
Mkt Cap9.07M
Eagle Pharmaceuticals, Inc. focuses on critical care and oncology, including therapies that could be used in conjunction with wound healing processes.

About

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Show more...
CEO
ISIN
IL0011316309

Listings

BOATS
BOATS
MDWD.BOATS
F
DE
M8W.F
XNAS
US
MDWD

0 Comments

Share your thoughts

FAQ

What is MediWound stock price today?▼
The current price of MDWD.BOATS is $18.26 USD — it has increased by +0% in the past 24 hours. Watch MediWound stock price performance more closely on the chart.
What is MediWound stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange MediWound stocks are traded under the ticker MDWD.BOATS.
What is MediWound market cap?▼
Today MediWound has the market capitalization of 201.26M
When is the next MediWound earnings date?▼
MediWound is going to release the next earnings report on June 03, 2026.
What were MediWound earnings last quarter?▼
MDWD.BOATS earnings for the last quarter are -0.56 USD per share, whereas the estimation was -0.65 USD resulting in a +13.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MediWound revenue for the last year?▼
MediWound revenue for the last year amounts to 40.44M USD.
What is MediWound net income for the last year?▼
MDWD.BOATS net income for the last year is -60.45M USD.
When did MediWound complete a stock split?▼
MediWound has not had any recent stock splits.